Testing for Primary Aldosteronism and Mineralocorticoid Receptor Antagonist Use Among U.S. Veterans : A Retrospective Cohort Study.
CONCLUSION: In a nationally distributed cohort of veterans with apparent treatment-resistant hypertension, testing for primary aldosteronism was rare and was associated with higher rates of evidence-based treatment with MRAs and better longitudinal BP control. The findings reinforce prior observations of low adherence to guideline-recommended practices in smaller health systems and underscore the urgent need for improved management of patients with treatment-resistant hypertension.
PRIMARY FUNDING SOURCE: National Institutes of Health.
PMID: 33370170 [PubMed - as supplied by publisher]
Source: Annals of Internal Medicine - Category: Internal Medicine Authors: Cohen JB, Cohen DL, Herman DS, Leppert JT, Byrd JB, Bhalla V Tags: Ann Intern Med Source Type: research
More News: Endocrinology | Hypertension | Internal Medicine | Primary Care | Study | Urology & Nephrology